| Record ID | marc_oregon_summit_records/catalog_files/osu_bibs.mrc:672622965:1641 |
| Source | Oregon Libraries |
| Download Link | /show-records/marc_oregon_summit_records/catalog_files/osu_bibs.mrc:672622965:1641?format=raw |
LEADER: 01641cam a2200421 i 4500
001 3885641
003 OR
008 940418s1978 mdua b f000 0 eng d
020 $cpbk.
035 $a10699748
037 $b20014
040 $aGPO$cGPO$dMvI
049 $aORE1$lbna
074 $a507-G-12
086 $aHE 20.3159/2:76
086 $aHE 20.3159/2:76
099 $aHE 20.3159/2:76
110 2 $aNational Cancer Institute (U.S.).$bDivision of Cancer Cause and Prevention.
245 10 $aBioassay of tris (2,3-dibromopropyl) phosphate for possible carcinogenicity.
260 $aBethesda, Md. :$bDept. of Health, Education, and Welfare, Public Health Service, National Institutes of Health, National Cancer Institute, Division of Cancer Cause and Prevention, Carcinogenesis Testing Program,$c1978.
300 $a117 p. in various pagings :$bill. ;$c27 cm.
490 1 $aCarcinogenesis technical report series ; no. 76.
490 1 $aDHEW publication ; no. (NIH) 78-1326.
500 $aSpine title: Tris (2,3-dibromopropyl) phosphate.
500 $a"CAS no. 126-72-7."
504 $aBibliography: p. 61-62.
650 0 $aCarcinogens.
650 0 $aDibromopropanol phosphate$xToxicology.
650 0 $aFireproofing agents$xToxicology.
740 0 $aTris (2,3-dibromopropyl) phosphate.
810 2 $aNational Cancer Institute (U.S.).$tCarcinogenesis technical report series ;$vno. 76.
830 0 $aDHEW publication ;$vno. (NIH) 78-1326.
907 $a.b16386589$bvdo $c-
902 $a990521
998 $b1$c981001$dm$ea$f-$g0
937 $aAssessment exclusion record.
999 $a19940418094856.0
945 $lvdog $e1